I have sometimes pondered the bravery and sacrifice that Clinical Trial patients and their families endure as they participate in Treatment - type clinical trials for new drugs and drugs combinations, from Phase I trials to Phase III trials, especially.
Their life and death situations are often just as immediate and poignant as military service is for some of our service men and women in combat zones, while on active duty, and even unto death while in service.
Should some version of the military's Hazardous Duty Incentive Pay and the military Death Gratuity program be adopted by appropriate legislation/regulation/financing involving the Department of Health and Human Services (HHS) Office for Human Research Protections and Clinical Trials Institutional Review Boards for select patients who bravely sacrifice to participate in Treatment-type Clinical Trials?
"Discuss among yourselves.".......